The BioBeat24 half-day event, held at the Sainsbury Wellcome Centre in central London in May 2024, was all about exploring emerging opportunities both from research and clinical perspectives as well as understanding the fundraising environment for entrepreneurs. The UK Dementia Research Institute and BioBeat were co-organisers.
Ahead of BioBeat24, Iraida Soria-Espinosa, Senior Innovation & Business Manager at UK DRI, and Miranda Weston-Smith, Founder of BioBeat, caught up with keynote speaker Zoe Kourtzi, Professor of Computational Cognitive Neuroscience at the University of Cambridge.
BioBeat24: Driving solutions in neurodgeneration with digital will take place at the Sainsbury Wellcome Centre, London in the afternoon of 16 May 2024.
Zoe, we are thrilled you are delivering the keynote,
» Read more about: A critical time for AI, dementia and better brain health »
BioBeat23 provided a platform for investors, entrepreneurs, and industry experts to delve into the evolving world of biotechnology. Against the backdrop of economic adversity, this gathering of minds shed light on the key mindsets and strategies required for success in the biotech industry. Organised by Miranda Weston-Smith, Founder of BioBeat, and Alisa Molotova, Investment Manager at Martlet Capital, the event provided valuable insights for biotech industry professionals.
Ahead of BioBeat23, Miranda Weston-Smith, BioBeat founder, talks to Alisa Molotova, Investment Manager at Martlet and co-organiser of BioBeat23, about her investment journey.
Miranda: It’s a total pleasure working with you on BioBeat23: Out of adversity comes opportunity on 18 May at the Cambridge Union. I’m curious to know, how did you get into biotech investing?
Alisa: I spent years in the lab studying the intricacies of cellular biology and regenerative medicine.
» Read more about: A newcomer’s view on heatlthcare investment »
On 19 November, the UK BioBeat19 summit goes to Stevenage to discuss the potential of cell and gene therapy and how to accelerate these transformational medicines. The organisers from GSK and BioBeat spoke to two panellists who gave a sneak peek of their remarks and agree wholeheartedly that the discovery side and clinical side work best when they are teamed up.
Sophie Papa, an oncologist at Guy’s Cancer at Guy’s and St Thomas’ NHS Trust,
» Read more about: Next generation cell & gene therapies: fine tuning the promise »
Every day huge amounts of data are captured and with it our ability to harvest new biological insights to improve healthcare for everyone. The technological possibilities are vast. At the BioBeat18 summit: Disrupting biodata healthcare, leaders will explore how to build sustainable biodata healthcare businesses. The congress will take place on 15 November at the Wellcome Genome Campus.
Ahead of the forum, we (Jo Mills, Entrepreneurship and Innovation Manager at the Wellcome Genome Campus,
» Read more about: BioBeat18: Usability challenges of biodata in healthcare »
Miranda has mentored and judged the IMAGINE IF! competition and accelerator programme in Cambridge for several years. We talk to her about being a mentor, the life sciences sector in Cambridge, and creating successful ventures.
Innovation Forum Cambridge (IFC): Why have you committed yourself as a mentor?
Miranda: The bio entrepreneurs the Innovation Forum attracts to IMAGINE IF! are impressive. They are bold, practical and ambitious to make the world a healthier place.
» Read more about: Innovation Forum Cambridge interviews IMAGINE IF! Mentor Miranda Weston-Smith »
As an advocate of innovation and collaboration in life science, BioBeat has recently released its 50 Movers and Shakers in BioBusiness 2017 report. This demonstrates the remarkable achievements of 50 women leaders and entrepreneurs across five key themes encompassing the entire bioscience translational spectrum. In four previous blogs, we explored the themes: Great Science, Financial Enablers, Collaboration, and Patient Impact.
In its ongoing support of this cause, BioBeat has recently released its 50 Movers and Shakers in BioBusiness 2017 report, recognising the remarkable impact that women leaders and entrepreneurs are making in life science across five key translational themes. In three previous blogs, we explored the report’s Great Science, Financial Enablers, and Collaboration themes. Below we look at the Patient Impact theme,
» Read more about: BioBeat’s Movers and Shakers 2017: Who’s helping to improve patient care? »
As an innovative collaborative platform for bioscience, BioBeat recently released its 50 Movers and Shakers in BioBusiness 2017 report. This demonstrates the exceptional leadership in life science across five key translational themes. In the last two blogs, we focused on the report’s Great Science and Financial Enablers themes, which recognized 10 talented scientists and 10 financial experts who are making a significant impact towards solving our global healthcare challenges.
As a collaborative platform for nurturing outstanding talent in UK bioscience, BioBeat publishes its annual Movers and Shakers in BioBusiness report to demonstrate the achievements of women leaders and entrepreneurs. This year the report recognises 50 of these talented women working across five key translational themes: Great Science, Financial Enablers, Collaboration, Patient Impact, and Infrastructure Innovation.
Below we focus on the report’s Financial Enablers theme, in which ten women leaders (including six Rising Stars) are recognised for driving exceptional investment and growth in the life sciences – and ultimately helping to make a difference to patients’ lives.
Now in its fifth year, BioBeat is a collaborative innovation platform for business entrepreneurs and leaders in bioscience. BioBeat’s Movers and Shakers annual report demonstrates how talented women in biobusiness are driving innovation in life science. This year the report recognises 50 outstanding women leaders across five key translational themes: Great Science, Financial Enablers, Collaboration, Patient Impact, and Infrastructure Innovation. Below we focus on the report’s Great Science theme and find out about those women who have been making great scientific advances towards giving us a healthier world.
Urgency to improve global health. This was the over-riding mentoring need of life science entrepreneurs at the recent IECT Summer School on Entrepreneurship in the Austrian Tyrol. The life science delegates from Austria, Germany, Israel, Hong Kong, and the UK shared a strong commitment to deliver the best possible technology solutions to make the world healthier for us all.
Founded in 2015 by Hermann Hauser in the UK and Josef Hauser in Austria,
Now in its fourth year, BioBeat, founded by Miranda Weston-Smith, is a collaborative platform for entrepreneurs and leaders in the biotech industry. BioBeat’s annual Movers and Shakers report honours women in biobusiness who are setting the pace in the life science sector and delivering extraordinary success in their field. To celebrate this Autumn’s BioBeat16 event and the publication of this year’s report, we’ve been speaking to some of 2015’s Movers and Shakers to explore how they’re transforming today’s challenges into tomorrow’s opportunities.
How do we nurture growth in the life science sector and ensure the UK is the best place to develop innovative patient therapies in these turbulent times? These are some of the questions that were discussed at the BioBeat16 summit, held on 16th November 2016 in Cambridge. Around 160 delegates, including life science academics, biobusiness leaders, industry experts and investors gathered at St Catharine’s College for an evening of networking and a panel discussion on the theme of Stretching Biotech Pharma Entrepreneurship.
» Read more about: Top Trends at BioBeat16: Stretching biotech pharma entrepreneurship »
Now in its fourth year, BioBeat, founded by Miranda Weston-Smith, is a collaborative platform for entrepreneurs and leaders in the biotech industry. BioBeat’s annual Movers and Shakers report honours women in biobusiness who are setting the pace in the life science sector and delivering extraordinary success in their field. To celebrate this Autumn’s BioBeat16 event and the publication of this year’s report, we’ve been speaking to some of 2015’s Movers and Shakers to explore how they’re transforming today’s challenges into tomorrow’s opportunities.
Now in its fourth year, BioBeat, founded by Miranda Weston-Smith, is a collaborative platform for entrepreneurs and leaders in the biotech industry. BioBeat’s annual Movers and Shakers report honours women in biobusiness who are setting the pace in the life science sector and delivering extraordinary success in their field. In the run up to this November’s BioBeat16 event, we speak to some of 2015’s Movers and Shakers to explore how they’re transforming today’s challenges into tomorrow’s opportunities.
Now in its fourth year, BioBeat, founded by Miranda Weston-Smith, is a collaborative platform for entrepreneurs and leaders in the biotech industry. BioBeat’s annual Movers and Shakers report honours women in biobusiness who are setting the pace in the life science sector and delivering extraordinary success in their field. In the run up to this November’s BioBeat16 event, we speak to some of 2015’s Movers and Shakers to explore how they’re transforming today’s challenges into tomorrow’s opportunities.
Now in its fourth year, BioBeat, founded by Miranda Weston-Smith, is a collaborative platform for entrepreneurs and leaders in the biotech industry. BioBeat’s annual Movers and Shakers report honours women in biobusiness who are setting the pace in the life science sector and delivering extraordinary success in their field. In the run up to this November’s BioBeat16 event, we speak to some of 2015’s Movers and Shakers to explore how they’re transforming today’s challenges into tomorrow’s opportunities.
Now in its fourth year, BioBeat, founded by Miranda Weston-Smith, is a collaborative platform for entrepreneurs and leaders in the biotech industry. BioBeat’s annual Movers and Shakers report honours women in biobusiness who are setting the pace in the life science sector and delivering extraordinary success in their field. In the run up to this November’s BioBeat16 event, we speak to some of 2015’s Movers and Shakers to explore how they’re transforming today’s challenges into tomorrow’s opportunities.
